JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4176
iShares Global Healthcare ETF
IXJ
$4.28B
| $162K | ﹤0.01% |
2,670
| – | – |
2014 Q4
21 quarters
|
|
4177
Anterix
ATEX
$1.64B
| $161K | ﹤0.01% |
3,528
-688
| -16% | -$31.1K |
2017 Q4
9 quarters
|
|
|
AXNX
4178
DELISTED
Axonics, Inc. Common Stock
AXNX
| $161K | ﹤0.01% |
6,325
+1,231
| +24% | +$36.6K |
2018 Q4
5 quarters
|
|
|
MLVF
4179
DELISTED
Malvern Bancorp, Inc.
MLVF
| $161K | ﹤0.01% |
13,125
+3,254
| +33% | +$62.4K |
2017 Q4
9 quarters
|
|
4180
CALL
Ligand Pharmaceuticals
LGND
$6.14B
| $160K | ﹤0.01% |
+3,527
| New | +$200K |
2020 Q1
0 quarters
|
|
4181
Unity Bancorp
UNTY
$550M
| $160K | ﹤0.01% |
13,762
+2,692
| +24% | +$50.2K |
2017 Q4
9 quarters
|
|
|
LEVL
4182
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $160K | ﹤0.01% |
8,866
+1,737
| +24% | +$40.4K |
2018 Q2
7 quarters
|
|
4183
iShares Global 100 ETF
IOO
$9.3B
| $159K | ﹤0.01% |
3,559
-2,149
| -38% | -$110K |
2017 Q2
11 quarters
|
|
4184
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
| $158K | ﹤0.01% |
600
| – | – |
2019 Q2
3 quarters
|
|
|
4185
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
| $158K | ﹤0.01% |
600
| – | – |
2019 Q2
3 quarters
|
|
4186
ProShares UltraPro Short S&P 500
SPXU
$403M
| $158K | ﹤0.01% |
65
+37
| +132% | +$83.1K |
2018 Q4
5 quarters
|
|
|
CFMS
4187
DELISTED
Conformis, Inc. Common Stock
CFMS
| $158K | ﹤0.01% |
10,063
-14,168
| -58% | -$346K |
2019 Q2
3 quarters
|
|
|
RWVG
4188
DELISTED
Direxion Russell 1000 Value Over Growth ETF
RWVG
| $158K | ﹤0.01% |
+4,099
| New | +$206K |
2020 Q1
0 quarters
|
|
|
EGLE
4189
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $158K | ﹤0.01% |
12,231
-1,592
| -12% | -$35.4K |
2017 Q4
9 quarters
|
|
4190
Invesco S&P Spin-Off ETF
CSD
$218M
| $157K | ﹤0.01% |
+5,500
| New | +$235K |
2020 Q1
0 quarters
|
|
4191
Hyster-Yale Materials Handling
HY
$575M
| $157K | ﹤0.01% |
3,918
+593
| +18% | +$29.9K |
2013 Q2
27 quarters
|
|
4192
Aldeyra Therapeutics
ALDX
$56M
| $156K | ﹤0.01% |
63,340
+55,946
| +757% | +$252K |
2017 Q4
9 quarters
|
|
4193
American Coastal Insurance
ACIC
$439M
| $155K | ﹤0.01% |
16,835
+10,075
| +149% | +$102K |
2017 Q2
11 quarters
|
|
4194
Peoples Bancorp of North Carolina
PEBK
$237M
| $155K | ﹤0.01% |
7,637
+1,661
| +28% | +$44.6K |
2017 Q4
9 quarters
|
|
4195
Telkom Indonesia
TLK
$12.7B
| $155K | ﹤0.01% |
8,057
-231,710
| -97% | -$5.85M |
2013 Q2
27 quarters
|
|
4196
Invesco Preferred ETF
PGX
$3.6B
| $154K | ﹤0.01% |
11,671
+1,640
| +16% | +$23.6K |
2014 Q4
21 quarters
|
|
|
CYBE
4197
DELISTED
Cyberoptics Corp
CYBE
| $154K | ﹤0.01% |
8,987
-8,723
| -49% | -$177K |
2019 Q1
4 quarters
|
|
4198
Century Casinos
CNTY
$29.5M
| $153K | ﹤0.01% |
63,102
+41,454
| +191% | +$269K |
2017 Q4
9 quarters
|
|
4199
First Northwest Bancorp
FNWB
$93.9M
| $153K | ﹤0.01% |
14,164
+498
| +4% | +$7.63K |
2017 Q4
9 quarters
|
|
4200
Invesco Solar ETF
TAN
$891M
| $153K | ﹤0.01% |
6,077
-12,938
| -68% | -$422K |
2017 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.